Quick Facts
  • Primary Location:
    Tennessee Oncology
  • Expertise:
    Bone Marrow Biopsies
  • Speciality:
  • Gender:
  • Language:
  • Med School:
    University of Tennessee, Memphis

Get to Know Dr. Edward Kirk Barnes

Medical oncologist Dr. Edward Kirk Barnes handles chemotherapy treatment for malignant mesothelioma patients at the TriStar Skyline Medical Center and the TriStar Centennial Medical Center.

Barnes specializes in hematology with Tennessee Oncology, a community based group of specialists with convenient locations throughout the area.

He also is affiliated with the Sarah Cannon Research Institute, which allows him to utilize the latest treatment advances for his patients.

With more than 20 years of experience, Barnes treats a wide range of adult malignancies, including lung cancer, malignant mesothelioma, blood cancers and leukemia.

Barnes works closely with Dr. Michel Kuzur and Dr. David Spigel at Tennessee Oncology. They coordinate their efforts to provide the best possible treatment for each patient.

Contact Edward Kirk Barnes
By submitting, you agree to our privacy policy and disclaimer. Our Patient Advocates may contact you via phone, email and/or text.

Specialties of Dr. Edward Kirk Barnes

  • Internal medicine
  • Hematology
  • Chemotherapy
  • Bone marrow biopsies
  • Blood transfusions

Dr. Edward Kirk Barnes’ Experience and Medical Education

  • Tennessee Oncology
  • University of Tennessee College of Medicine (M.D.)
  • Vanderbilt University School of Medicine (Fellowship)
  • Saint Thomas Midtown Hospital (Internship and residency)

Awards and Other Recognitions

  • Healthgrades Honor Roll
  • Patient Safety Award
  • Nashville Academy of Medicine

Publications of Dr. Edward Kirk Barnes

  • Bendell, J. et al. (2017, April 20). A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer. Epub.
  • Spigel, D. et al. (2012). Phase II Study of Bevacizumab and Chemoradiation in the Preoperative or Adjuvant Treatment of Patients With Stage II/III Rectal Cancer. Clinical Colorectal Cancer.

Lab technician using a microscope in a lab
COVID-19 and Mesothelioma Presentation
United States one-hundred-dollar bills
Access More than $32 Billion in Trust Funds
Technician documenting notes in a lab
Find Active Mesothelioma Clinical Trials

Tell us what you think
Did this article help you?
How did this article help you?
What about this article isn’t helpful for you?
Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?